PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB:RXMD), has announced the broadening of its in-pharmacy offerings through a partnership with the Mark Cuban Cost Plus Drug Company ("Cost Plus Drugs"). The Cost Plus Drugs program empowers participating patients to purchase generic and branded medicines at their cost plus a minimal fixed markup.
The Mark Cuban Cost Plus Drug Company ("MCCPDC") provides access to over 1,000 drugs at their actual acquisition cost plus a transparent 15% markup. Recently, MCCPDC introduced the Team Cuban Card, a complimentary prescription benefit program that grants consumers access to affordable medications nationwide.
Under the collaboration with MCCPDC, PharmcoRx locations will be featured as participating pharmacies in the Team Cuban Card provider directory. The pharmacy will actively promote the acceptance of the program to its existing customer base and within its network of local clinics and healthcare practices.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!